FDA Inspection 1320016 — Jo-Anne H. Young, MD, FACP

Jo-Anne H. Young, MD, FACP — FEI 3007864579

The FDA completed an inspection of Jo-Anne H. Young, MD, FACP on May 21, 2026 in Minneapolis, MN. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
May 21, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Bioresearch Monitoring
Location
Minneapolis, MN (United States)

Additional Details

Clinical Investigator (CI)